Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 14, Pages 1847-1856
Publisher
Springer Nature
Online
2015-06-29
DOI
10.1038/onc.2015.250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
- (2014) W. M. Lau et al. CANCER RESEARCH
- Regulation of alternative splicing of CD44 in cancer
- (2014) Lubomir Prochazka et al. CELLULAR SIGNALLING
- Cancer Stem–like Cell Marker CD44 Promotes Bone Metastases by Enhancing Tumorigenicity, Cell Motility, and Hyaluronan Production
- (2013) Toru Hiraga et al. CANCER RESEARCH
- SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
- (2012) Rong Jia et al. International Journal of Biological Sciences
- The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
- (2012) Michal Cohen-Eliav et al. JOURNAL OF PATHOLOGY
- Regulation of CXCR4-Mediated Invasion by DARPP-32 in Gastric Cancer Cells
- (2012) S. Zhu et al. MOLECULAR CANCER RESEARCH
- Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms
- (2012) S. Erkelenz et al. RNA
- The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B
- (2012) E. S. Anderson et al. RNA
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DARPP-32 Increases Interactions Between Epidermal Growth Factor Receptor and ERBB3 to Promote Tumor Resistance to Gefitinib
- (2011) Shoumin Zhu et al. GASTROENTEROLOGY
- Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface
- (2011) Taavi Päll et al. PLoS One
- De novo expression of CD44 variants in sporadic and hereditary gastric cancer
- (2010) Cristiana Branco da Cunha et al. LABORATORY INVESTIGATION
- Rapid-Response Splicing Reporter Screens Identify Differential Regulators of Constitutive and Alternative Splicing
- (2010) I. Younis et al. MOLECULAR AND CELLULAR BIOLOGY
- Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis
- (2010) Kaushik Mukherjee et al. SURGERY
- CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification
- (2009) Pamela Klingbeil et al. BREAST CANCER RESEARCH AND TREATMENT
- Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers
- (2009) Sophie Hamel et al. BREAST CANCER RESEARCH AND TREATMENT
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells
- (2008) A. Belkhiri et al. CLINICAL CANCER RESEARCH
- Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20
- (2008) R. Jia et al. JOURNAL OF VIROLOGY
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer
- (2008) Liqiang Xi et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation